Genfit’s Post-NASH Plans Center On ACLF, Cholestatic Liver Disease

 
• By Joseph Haas
  
Brainstorming Group of people Working Concept. Business team brainstorming. Marketing plan researching. Paperwork on the table, laptop and mobile phone.
Genfit is moving on from NASH, into rare liver indications
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business